Journal: Anticancer research

Article Title: Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats.

PMID/MRN: 27798866

Publication Date: 2016-Oct-01

Abstract:

The circulatory pathway for particles deposited outside of blood capillaries has not been well characterized for non-traditionally-delivered chemotherapeutics. Blood and lymph pharmacokinetics of docetaxel (5 mg/kg) and carboplatin (14 and 28 mg/kg) following subcutaneous (s.c.) versus intravenous (i.v.) delivery were determined in a rodent model with catheterizations of both the thoracic lymphatic duct and jugular vein for prolonged synchronous blood and lymph sampling. Subcutaneous docetaxel demonstrates preferential lymphatic accumulation based on the area under the time-concentration curve (AUC 0-24h ) whereas i.v. docetaxel resulted in a greater plasma maximum concentration measured (C max ). The apparent elimination half-life (t 1/2 ) in lymph for docetaxel is greater following i.v. or s.c. delivery compared to t 1/2 in blood. Carboplatin demonstrates a dose-dependent increase in plasma C max regardless of delivery route; the total carboplatin exposure over 24 h in lymph and plasma are comparable. Subcutaneous docetaxel achieves lymphatic accumulation greater than that of i.v. delivery. Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.